BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Bleomycin
,
rs3825942
,
DNMT1
,
Response to oxidative stress
,
Obesity
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
b- cell- lymphoma
Summary
General Info
Curated Studies
Most Correlated Studies
Cancer Gene Census - mutations in cancer genes
Canine lymphomas analyzed by breed and subtype
OMIM - Cancer
OMIM - Malignant neoplasms
EZH2 mutant and wild type DLBCL cell lines treated with a EZH2 inhibitor
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinical applications of circulating tumor DNA in indolent B-cell lymphomas.
Expression of BCL11A in chronic lymphocytic leukaemia.
CAR T-cell therapy for B-cell lymphoma.
The Novel Role of the B-Cell Lymphoma/Leukemia 11A (BCL11A) Gene in β-Thalassaemia Treatment.
Cyclin-D1 positive B cell lymphoma with intravascular and interstitial involvement of kidney and bon…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Multi-CAR-T Cells Targeting B Cell Lymphomas
R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma
Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell …
Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma
Omic Technologies Applied to the Study of Diffuse Large B-cell Lymphoma and High-grade B-cell Lympho…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ